Maciej Drożdż

Maciej Drożdż

---

Maciej Drożdż, PhD from the University of Heidelberg and MBA from SBS University of Oxford. Investor in venture capital funds, including Atlas Ventures, Entrepreneurs Fund, and JJDC – the corporate fund of Johnson & Johnson. Former member of supervisory boards for numerous companies across several European countries, such as SuperX, Cambridge, UK; Syndesi Therapeutics, Brussels, Belgium; Cealus Health, Amsterdam, Netherlands; Sequana Medical, Zurich, Switzerland; Protaffin, Graz, Austria. Founder, co-founder, or private investor in companies including Antagonis Therapeutics in Graz, Austria; MiMo Biotech, Poland; Cytoo SA, Grenoble/Paris, France.